发明名称 |
Nerve growth factor as a vaccine adjuvant |
摘要 |
A vaccination method utilizes a pharmaceutical combination for enhancing vaccine effectiveness. The method utilizes an immune response-triggering vaccine capable of stimulating production in an immunodeficient animal antibodies to a disease-causing agent foreign to the animal. As an adjuvant, a vaccine effectiveness-enhancing amount of Nerve Growth Factor (NGF) is administered, which enhances production and affinity of the antibodies in the animal, in response to the vaccine.
|
申请公布号 |
US6572866(B1) |
申请公布日期 |
2003.06.03 |
申请号 |
US19990269883 |
申请日期 |
1999.06.01 |
申请人 |
PROTECHTION UNLIMITED, INC. |
发明人 |
TORCIA MARIA |
分类号 |
A61K38/22;A61K39/02;A61K39/04;A61K39/08;A61K39/145;A61K39/205;A61K39/245;A61K39/285;A61K39/29;A61K39/39;(IPC1-7):A61K47/42 |
主分类号 |
A61K38/22 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|